All

Results: 62113-62124 of 66207

PR Newswire associated0

Octapharma AG: Indirect comparison data indicate that personalised prophylaxis with Nuwiq® may lead to fewer patients with haemophilia A having bleeds than with other recombinant factor VIII products

CYB003 (12mg dose) demonstrated a rapid and statistically significant reduction in symptoms of depression at three weeks after a single dose, meeting the primary efficacy endpoint (Graphic: Business Wire)

Cybin Announces Unprecedented Positive Phase 2 Interim Data for CYB003 in Major Depressive Disorder Meeting Primary Efficacy Endpoint with Rapid and Significant Improvements in Depression Symptoms After Single Dose

One in 10 Brits deliberately cough in people’s faces, research finds

PR Newswire associated0

HOYA Vision Care Releases One-Year MiYOSMART European Study Results

Porsche plans to use CO2-reduced steel from H2 Green Steel in sports cars from 2026

Options Announces New Five-Year Global Investment in Pure Storage (Graphic: Business Wire)

Options Transforms Data Services with New Five-Year Global Investment in Pure Storage

PR Newswire associated0

Clario presents a three-part webinar series on oncology trial solutions

GlobeNewswire associated0

Aduro Clean Technologies Upgrades to OTCQX Best Market; Top Tier of the OTC Markets

OKYO Pharma Announces $5.84 Million Cash Raise and Payables Reduction

PR Newswire associated0

Marlabs announces Thomas Collins as new CEO

FourKites Appoints Bill Maw as Chief Financial Officer (Photo: Business Wire)

FourKites Appoints Industry Veteran Bill Maw as Chief Financial Officer to Drive Continued Growth

Blackline Safety Announces Credit Facility Expansion with ATB Financial to $25 Million